EN PL

GMP: FDA finalizes Guidelines for Biosimilars

21.05.2015
In February 2009, the US Food and Drug Administration has published three draft guidance documents on the development of biosimilars. Now, on 15 April, the FDA issued the finalized version of these three documents.